Expert Video - Why are Black American lung cancer patients less likely to participate in clinical trials?
Janine Harewood, MD, discusses Black Americans' medical distrust as a barrier to lung cancer clinical trial participation. Many Black Americans are less likely to participate in clinical trials for lung cancer due to social and economic factors that affect Black healthcare, such as low access and a lack of lung cancer treatment options and low Black American awareness of lung cancer clinical trials.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
Please rate this content:
Other Modules:
Animation - Lung Cancer Clinical Trials and the US Black Community
Slide Show - Lung Cancer Clinical Trials and the US Black Community
1.
How prevalent is lung cancer among Black Americans? Why is it so prevalent?
2.
Why is lung cancer diagnosed at a later stage among Black Americans compared to other Americans?
3.
What are the potential benefits of clinical trials for Black American lung cancer patients? What about risks?
4.
Why are Black American lung cancer patients less likely to participate in clinical trials?
5.
What is health equity and why is it important in lung cancer care?
6.
What historical events have impacted Black Americans' involvement in clinical trials?
7.
Why is it important from a scientific perspective to have more Black Americans in clinical trials?
8.
Why do current screening guidelines miss a significant portion of Black Americans at risk of lung cancer?
9.
How was your lung cancer diagnosed and how did you find out about your clinical trial?
10.
What was the clinical trial enrollment process like for you?
11.
What was your overall experience in the lung cancer clinical trial?
12.
What advice do you have for other people about participating in clinical trials?
